Welcome to PrEP Watch, a comprehensive
information source on pre-exposure prophylaxis for HIV prevention
Pre-exposure prophylaxis (PrEP) refers to an experimental HIV-prevention strategy that would use antiretrovirals to protect HIV-negative people from HIV infection. PrEP is not proven to work; in the strategy that is currently being tested, HIV-negative people would take a single drug, or a combination of drugs, with the hopes that it would lower the risk of infection if exposed to HIV. Along with AIDS vaccines and microbicides, PrEP is one of the experimental HIV prevention strategies being tested in clinical trials today.
PrEP Watch features a regularly-updated table of planned and ongoing trials as well as current information including scientific findings, advocacy documents, and meeting reports. .
